Daxor Corporation (DXR)

11.85 -2.04 (-14.687%)

IEX Real-Time Price

March 20, 2018 EST.

NYSE American : Healthcare

Prev Close 13.89

Price Open 13.28

Volume: 586,977

Avg Volume: 1.19M

Market Cap: 44.28M

P/E Ratio -

52 Wk Range 3.4001-21.66


Daxor up 156% on positive blood volume analysis data in heart failure patients (2018-03-15 13:15 SeekingAlpha)

Thinly traded nano cap Daxor ( DXR +156.4% ) rockets on a whopping 128x surge in volume in response to its announcement of real-world data that showed a significant benefit to heart failure patients from the use of blood volume analysis (BVA) performed on its BVA-100 analyzer. The resu…


Sunshine Heart Is In Play, Part 5: Aquadex Precision Guided Ultrafiltration Therapy Using Daxor BVA-100 - A Paradigm Shift In Heart Failure Management (2016-12-13 12:12 SeekingAlpha)

The Story So Far In this Part 5 of this series of articles it is useful to briefly summarize what has brought us to this point. In the Sunshine Heart second quarter conference call on August 9, 2016, Chairman & CEO Mr John Erb announced the strategic acquisition of Aquadex FlexFlow p…


Daxor Corp declares $0.03 dividend (2016-11-18 15:26 SeekingAlpha)

Daxor Corp (NYSEMKT: DXR ) declares $0.03/share annual dividend , -25% decrease from prior dividend of $0.04. More news on: Daxor Corp, Dividend news, , Read more …


Daxor Corp declares $0.04 dividend (2015-12-10 08:35 SeekingAlpha)

Daxor Corp (NYSEMKT: DXR ) declares $0.04/share annual dividend , 33.3% increase from prior dividend of $0.03. More news on: Daxor Corp, Dividend news Read more …


Daxor's March Toward 'Standard Of Care' (2015-05-19 11:31 SeekingAlpha)

On April 10 of 2015, this year, Daxor (NYSEMKT: DXR ) led Seeking Alpha's midday gainers list, making a striking 27% jump in price. This price move, to over $9.00, was accompanied by sharp volume increases. Price has since settled back to the $7 level, but still shows uncharacteristic volume a…



Shares Outstanding: 3.74M

Top 15 Institution Percent: 3.20

Price To Sales: -36.05

Price To Book: 1.15

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -5.79

Return On Equity: -2.62

Profit Margin: 88.60

Price History

Beta: -0.23

50-day Moving Avg: 4.86

200-day Moving Avg: 5.29

YTD Change: 170.00

5-day Change: 51.93

1-month Change: N/A

3-month Change: 152.84

6-month Change: 133.65

1-year Change: 66.81

Revenue Per Share: 0.00

Revenue Per Employee: 0.00


Dividend Yield: 0.22

EX-Dividend Date: 2018-01-05

Dividend Rate: 0.03

Company Profile

Name: Daxor Corporation

Exchange: NYSE American

Industry: Medical Instruments & Equipment

Sector: Healthcare

Website: http://www.daxor.com

Daxor Corp is a US-based biotechnology company which provides original medical equipment for medical personnel. It manufactures the BVA-100 Blood Volume Analyzer that provides a rapid direct measurement of a patient's blood volume.